From: PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome
Covariables | Hazard ratio | 95% CI | p |
---|---|---|---|
Recurrence prediction | |||
 Metastases | 72.33 | 12.58–415.65 | << 0.001 |
 Surgical margins | 5.06 | 1.75–14.60 | 0.003 |
 Metastases-right side of primary tumor# | 0.18 | 0.03–0.88 | 0.035 |
RAI refractoriness prediction | |||
 Stage | 5.34e+09 | 1.42e+09 to 2.00e+10 | << 0.001 |
 PSMA expression ≥ 80% | 3.77e−09 | 7.18e−10 to 1.98e−08 | << 0.001 |
 PSMA expression 11–79%-stage# | 1.28e−09 | – | – |
Status at last follow-up prediction | |||
 Sex | 85.26 | 10.48 to 693.52 | << 0.001 |
 Histological subtype | 7.98e−10 | 2.34e−10 to 2.73e−09 | << 0.001 |
 Sex-histological subtype# | 7.64e+08 | – | – |
 Sex-vascular invasion# | 0.01 | 0.00–0.09 | << 0.001 |